本页面由Tiger Trade Technology Pte. Ltd.提供服务

Embecta Corp.

10.61
+0.31003.01%
盘后10.610.00000.00%16:20 EST
成交量:79.51万
成交额:839.68万
市值:6.28亿
市盈率:6.55
高:10.65
开:10.22
低:10.22
收:10.30
52周最高:18.58
52周最低:9.20
股本:5,921.20万
流通股本:5,736.31万
量比:1.10
换手率:1.39%
股息:0.60
股息率:5.66%
每股收益(TTM):1.62
每股收益(LYR):1.64
净资产收益率:--
总资产收益率:16.59%
市净率:-0.97
市盈率(LYR):6.48

数据加载中...

公司资料

公司名字:
Embecta Corp.
交易所:
NASDAQ
成立时间:
1924
员工人数:
1850
公司地址:
300 Kimball Drive,Suite 300,Parsippany,New Jersey,United States
邮编:
07054
电话:
传真:
- -
简介:
Embecta Corp.于2021年7月8日在特拉华州成立。该公司是一家全球领先的医疗器械公司,专注于提供解决方案以改善糖尿病患者的健康和福祉。在百年基础下,该公司相信产品已成为世界上糖尿病管理领域最广泛认可和最受尊敬的品牌之一。该公司估计,该公司的产品被100多个国家的超3000万人用于胰岛素和糖尿病的日常管理。该公司拥有广泛的上市产品组合,包括各种笔针、注射器和安全设备,并辅以旨在帮助人们管理糖尿病的专有数字应用程序。

董事

名称
职位
Devdatt Kurdikar
Chief Executive Officer and Director and President
Carrie L. Anderson
Independent Director
Christopher R. Reidy
Independent Director
Claire Pomeroy
Independent Director
Karen N. Prange
Independent Director
Milton Morris
Independent Director
Robert J. Hombach
Independent Director

股东

名称
职位
Devdatt Kurdikar
Chief Executive Officer and Director and President
Ginny Blocki
Senior Vice President, Strategy
Jacob Elguicze
Chief Financial Officer and Senior Vice President
Jean Casner
Chief Human Resources Officer and Senior Vice President
Jeff Mann
General Counsel and Product Development and Senior Vice President
Shaun Curtis
Senior Vice President, Global Manufacturing, Supply Chain and Quality
Slobodan Radumilo
President, International and Senior Vice President
Tom Blount
President, North America and Senior Vice President
Anthony Roth
Chief Accounting Officer and Corporate Controller and Vice President